severe hemophilia a

Showing 1 - 25 of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

Severe Hemophilia A Trial in Iran, Islamic Republic of (Factor VIII, recombinant human with Fc fusion (rFVIII-Fc))

Completed
  • Severe Hemophilia A
  • Factor VIII, recombinant human with Fc fusion (rFVIII-Fc)
  • Isfahan, Iran, Islamic Republic of
  • +4 more
Nov 13, 2023

Severe Hemophilia A Trial in China (FRSW107)

Not yet recruiting
  • Severe Hemophilia A
  • Baoding, China
  • +13 more
Nov 16, 2023

Severe Hemophilia A Trial (Nuwiq)

Not yet recruiting
  • Severe Hemophilia A
  • (no location specified)
Jul 3, 2023

Dynamics of Anti-factor VIII Antibody Signature During Treatment

Not yet recruiting
  • Severe Hemophilia A
  • +2 more
  • no interventions
  • (no location specified)
Apr 4, 2023

Severe Hemophilia A, Moderate Hemophilia A Trial in Worldwide (Emicizumab)

Recruiting
  • Severe Hemophilia A
  • Moderate Hemophilia A
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Severe Hemophilia A Trial in China (ADVATE, FRSW117)

Completed
  • Severe Hemophilia A
  • Guangzhou, Guangzhou, China
  • +3 more
Jun 27, 2022

Severe Hemophilia A Trial in Poznan, Krakow (Alphanate SD/HT)

Completed
  • Severe Hemophilia A
  • Alphanate SD/HT
  • Poznan, Szkolna, Poland
  • +1 more
May 16, 2022

Severe Hemophilia A Trial in Sofia (OCTA101)

Terminated
  • Severe Hemophilia A
  • Sofia, Bulgaria
    Specialized Hospital for Active Treatment of Hematological Disea
Mar 31, 2022

Severe Hemophilia A, Osteoporosis Trial in Bron (radiation, biological, other)

Recruiting
  • Severe Hemophilia A
  • Osteoporosis
  • HR-pQCT
  • +3 more
  • Bron, France
    Hôpital Cardio-Vasculaire et Pneumologique
Feb 22, 2022

Hemophilia A, Severe Hemophilia A Trial in Worldwide (rVIII-SingleChain)

Completed
  • Hemophilia A
  • Severe Hemophilia A
  • rVIII-SingleChain
  • San Diego, California
  • +63 more
Sep 29, 2021

Severe Hemophilia A Trial in Duarte (VWF/FVIII concentrates)

Completed
  • Severe Hemophilia A
  • VWF/FVIII concentrates
  • Duarte, California
    City of Hope Medical Center
Aug 18, 2021

Severe Hemophilia A Trial in Worldwide (Human-cl rhFVIII)

Completed
  • Severe Hemophilia A
  • Human-cl rhFVIII
  • Sacramento, California
  • +14 more
Dec 21, 2020

Severe Hemophilia A Trial in Kirov, Kyiv, Lviv (Wilate)

Completed
  • Severe Hemophilia A
  • Kirov, Russian Federation
  • +2 more
Dec 21, 2020

Severe Hemophilia A Trial in Worldwide (Wilate)

Completed
  • Severe Hemophilia A
  • Sofia, Bulgaria
  • +6 more
Dec 21, 2020

Severe Hemophilia A Trial in Worldwide (Human cl rhFVIII)

Completed
  • Severe Hemophilia A
  • Human cl rhFVIII
  • Sacramento, California
  • +36 more
Dec 21, 2020

Severe Hemophilia A Trial in Worldwide (Factor VIII (rFVIIIFc), Advate®)

Completed
  • Severe Hemophilia A
  • Little Rock, Arkansas
  • +63 more
Dec 16, 2020

Severe Hemophilia A Trial in Hong Kong, Israel, United States (rFVIIIFc)

Completed
  • Severe Hemophilia A
  • Los Angeles, California
  • +6 more
Dec 16, 2020

Severe Hemophilia A Trial in Australia, New Zealand, United States (rFVIIIFc)

Completed
  • Severe Hemophilia A
  • rFVIIIFc
  • Los Angeles, California
  • +14 more
Dec 16, 2020

Severe Hemophilia A Trial in Australia, United Kingdom, United States (rFVIIIFc)

Completed
  • Severe Hemophilia A
  • rFVIIIFc
  • Los Angeles, California
  • +7 more
Dec 16, 2020

Severe Hemophilia A Trial (FVIII Concentrates, FVIII/VWF concentrates)

Withdrawn
  • Severe Hemophilia A
  • FVIII Concentrates
  • FVIII/VWF concentrates
  • (no location specified)
Dec 15, 2020

Severe Hemophilia A Trial in Washington, Sofia (Human-cl rhFVIII)

Completed
  • Severe Hemophilia A
  • Human-cl rhFVIII
  • Washington, District of Columbia
  • +1 more
Mar 3, 2020

Severe Hemophilia A Trial in Toronto (Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS))

Completed
  • Severe Hemophilia A
  • Recombinant Factor VIII (Advate/Helixate FS/KoegenateFS)
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Nov 18, 2019

Severe Hemophilia A Trial in Pittsburgh (Eloctate Prophylaxis, Emicizumab Prophylaxis, Eloctate ITI plus Emicizumab)

Withdrawn
  • Severe Hemophilia A
  • Eloctate Prophylaxis
  • +3 more
  • Pittsburgh, Pennsylvania
    Hemophilia Center of Western Pennsylvania
Aug 16, 2019

Severe Hemophilia A Trial in Worldwide (recombinant Factor VIII)

Completed
  • Severe Hemophilia A
  • recombinant Factor VIII
  • Wien, Austria
  • +10 more
Aug 9, 2017